Olema Oncology to Participate at the Jefferies 2021 Virtual Healthcare Conference

Rhea-AI Summary

Olema Pharmaceuticals, a clinical-stage biopharmaceutical company focused on women’s cancers, announced that CEO Sean P. Bohen will participate in a virtual fireside chat at the Jefferies 2021 Virtual Healthcare Conference on June 1, 2021, at 4:30 p.m. ET. The webcast will be available on Olema's website and archived for 14 days. Olema's lead candidate, OP-1250, is currently in a Phase 1/2 trial for ER-positive, HER2-negative breast cancer.

SAN FRANCISCO, May 18, 2021 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. (“Olema” or “Olema Oncology,” Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of targeted therapies for women’s cancers, today announced that Sean P. Bohen, M.D., Ph.D., President and Chief Executive Officer, will participate in a virtual fireside chat at the Jefferies 2021 Virtual Healthcare Conference on Tuesday, June 1, 2021 at 4:30 p.m. ET (1:30 p.m. PT).

A live webcast of the presentation may be accessed under the Investors & Media section of Olema’s website (www.olema.com) and will be archived for 14 days.

About Olema Oncology
Olema Oncology is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of targeted therapies for women’s cancers. Olema’s lead product candidate, OP-1250, is an orally-available small molecule with combined activity as both a complete estrogen receptor (ER) antagonist (CERAN) and a selective ER degrader (SERD). It is currently being evaluated as a single agent in an ongoing Phase 1/2 clinical trial in patients with recurrent, locally advanced or metastatic ER-positive (ER+), human epidermal growth factor receptor 2-negative (HER2-) breast cancer. Olema is headquartered in San Francisco.

Contact:
Eva Stroynowski
Vice President, Communications and Investor Relations
eva@olema.com
617-721-8194

FAQ

When will Olema Pharmaceuticals participate in the Jefferies 2021 Virtual Healthcare Conference?

Olema Pharmaceuticals will participate in the Jefferies 2021 Virtual Healthcare Conference on June 1, 2021, at 4:30 p.m. ET.

What is the focus of Olema Pharmaceuticals?

Olema Pharmaceuticals focuses on the discovery, development, and commercialization of targeted therapies for women’s cancers.

How can I access Olema's conference presentation?

The live webcast of Olema's conference presentation can be accessed on the Investors & Media section of Olema's website.

What is OP-1250 and its significance?

OP-1250 is Olema's lead product candidate, currently being evaluated for efficacy in treating ER-positive, HER2-negative breast cancer.